Despite this, directly targeting L-cells with agents (nutritional and/or gut microbial) to stimulate the endogenous production and secretion of GLP1 is still highly relevant as an alternative or combined treatment of obesity for various reasons [51]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.